High Absorption CoQ10 400 mg
Goals
$32.99 $0.54 per serving
Product analysis
High Absorption CoQ10 400 mg combines CoQ10 with black pepper for support of normal cellular energy production, with limited evidence for selected heart-related benefits. An absorption advantage is not established by the available details.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The CoQ10 and black pepper forms are identified, but their absorption quality remains uncertain. The high absorption claim cannot be confirmed from these details.
Ingredient Transparency100
The amounts and forms of both ingredients are disclosed. You can see what is included and compare servings with alternatives.
Value For Money88
The CoQ10 offers good value for the amount provided. There is not enough information to judge whether the black pepper adds value.
Customer Satisfaction91
Customers report very high satisfaction across a large review pool. The breadth of feedback makes the satisfaction picture more informative, without proving effectiveness.
Product Focus78
The formula remains centered on CoQ10, with black pepper as a supporting ingredient. Its main uses relate to cellular energy and selected heart-related outcomes, with benefits depending on the setting.
- Format
Capsule - Container
- 60 Veggie Cap(s)
- Per serving
- $0.54
- Also available
High Absorption CoQ10 100 mg$18.99- Customer rating
- 4.8 · 6,799 ratings
Goals
Impact
Moderate effect
Coenzyme Q-10 · 400 mg
CoQ10 at 400 mg supports mitochondrial energy production and antioxidant activity. Piperine may affect absorption, but neither the larger amount nor absorption enhancement establishes stronger anti-aging benefit. The supplied skin evidence remains specific to the reviewed preparation.
How this product is rated for Longevity
Ingredient fit93
The assessed ingredient mix is relatively focused on the goal’s biological processes. The counted amounts align well with the saved dose comparison ranges.
Goal fit
The assessed ingredient mix is relatively focused on the goal’s biological processes.
Dose adequacy
The counted amounts align well with the saved dose comparison ranges.
Pathways40
The strongest assessed connection is mitochondrial energy production, with moderate coverage. One mechanism reaches the saved coverage threshold; the contribution remains concentrated.
Depth
The strongest assessed connection is mitochondrial energy production, with moderate coverage.
Breadth
One mechanism reaches the saved coverage threshold; the contribution remains concentrated.
Evidence30
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension. The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Evidence strength
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension.
Studied preparation
The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No ingredient conflict was identified in the saved assessment. 1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflict was identified in the saved assessment.
Effective doses
1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Impact
Highest effect
Coenzyme Q-10 · 400 mg
CoQ10 has limited support for changes in blood pressure, blood lipids or blood-vessel function in adults with abnormal blood lipids. This serving provides 400 mg of ubiquinone, above that trial’s 120 mg amount, without establishing proportionately greater benefit. The findings concern selected cardiovascular markers and do not establish prevention of heart attacks or strokes or an added cardiovascular benefit from piperine.
How this product is rated for Cardiovascular Support
Ingredient fit93
CoQ10 provides a clear cardiovascular-marker connection, with full amount recognition and broader product goal links.
Goal fit
CoQ10 is the only included active, though the product is linked to several broader goals.
Dose adequacy
The 400 mg CoQ10 serving receives full amount recognition; exceeding the trial reference does not establish proportionately greater benefit.
Pathways60
The included connection is concentrated on blood-vessel lining function, with no comparable coverage of other cardiovascular routes.
Depth
CoQ10 makes blood-vessel lining function the strongest included route.
Breadth
Only blood-vessel lining function reaches the breadth requirement; other cardiovascular routes are not comparably covered.
Evidence88
CoQ10 has limited marker-based support in selected participants. The declared ubiquinone preparation receives recognition.
Evidence strength
CoQ10 supplies the evidence finding, based on limited cardiovascular-marker trials in selected populations.
Studied preparation
The declared CoQ10 active receives recognition without establishing a superior delivery form.
Formulation logic100
CoQ10 can contribute without an added partner, and no assessed conflict was found.
Partner coverage
CoQ10 can contribute without an added partner; no added benefit from piperine is established.
Conflicts
No assessed ingredient conflict was found in the supplied formulation.
Effective doses
CoQ10 meets the amount requirement used for inclusion.
Impact
Highest effect
Coenzyme Q-10 · 400 mg
CoQ10 participates in mitochondrial energy production, and this product identifies the ubiquinone form. The supplied evidence supports only limited, preparation-specific fatigue relief; results in clinical disease groups do not establish a routine energy increase in healthy adults. The serving reaches the saved amount reference, without showing that larger amounts provide greater benefit.
How this product is rated for Energy
Ingredient fit93
The ubiquinone serving reaches the saved amount reference; larger amounts do not establish more fatigue relief.
Goal fit
CoQ10 keeps the counted formula focused, while its links to other goals limit how specifically it targets energy.
Dose adequacy
The ubiquinone serving reaches the saved amount reference; larger amounts do not establish more fatigue relief.
Pathways53
The main contribution is concentrated in mitochondrial energy production, with partial coverage rather than demonstrated improvement across all forms of fatigue.
Depth
The main contribution is concentrated in mitochondrial energy production, with partial coverage rather than demonstrated improvement across all forms of fatigue.
Breadth
Only mitochondrial energy production reaches the saved breadth threshold.
Evidence84
CoQ10 supplies the evidence contribution, with limited preparation-specific fatigue findings and restricted transfer from clinical populations.
Evidence strength
CoQ10 supplies the evidence contribution, with limited preparation-specific fatigue findings and restricted transfer from clinical populations.
Studied preparation
Ubiquinone is explicitly identified; no absorption-superiority advantage is established.
Formulation logic100
The counted ingredients have no missing partner requirement or identified conflict. Their amounts meet the saved minimum counting criterion.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No matched ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients reach the saved minimum amount criterion; this is not a proven threshold for fatigue relief.
Impact
High effect
Coenzyme Q-10 · 400 mg
CoQ10 has limited support for blood-vessel function, blood-pressure and lipid measures from small studies in selected populations. The declared preparation and amount receive recognition, but those findings do not establish prevention of major cardiovascular events. No delivery advantage or extra benefit from a companion ingredient is established by the supplied facts.
How this product is rated for Heart Health
Ingredient fit80
The relevant ingredients provide a focused heart-health connection. The overall amount finding remains partial.
Goal fit
The recognized ingredients give a focused heart-health connection, although the product is also linked to other goals.
Dose adequacy
The 400 mg CoQ10 serving receives reduced recognition under the saved amount comparison; this is not measured loss of efficacy or a safety boundary.
Pathways47
The strongest saved connection is blood-vessel function. The contribution is concentrated in this route.
Depth
The strongest saved route is blood-vessel function, with coverage limited by the recognized preparation and amount.
Breadth
One route reaches the saved coverage threshold, so the contribution remains focused rather than broad.
Evidence98
Coenzyme Q-10 supplies the strongest recognized evidence, which concerns selected physiological measures rather than established general event prevention.
Evidence strength
Coenzyme Q-10 supplies the strongest recognized evidence, which concerns selected physiological measures rather than established general event prevention.
Studied preparation
The saved result recognizes studied preparations among the ingredients meeting its amount criteria; matching preparation does not guarantee the same clinical outcome.
Formulation logic100
No configured conflicts or missing required partners were found. The ingredients included in the amount finding clear its minimum threshold.
Partner coverage
The recognized ingredients work independently or have the required partners; no added combined benefit is established.
Conflicts
No configured ingredient conflicts were found in the supplied formula.
Effective doses
All ingredients included in this finding clear the saved minimum amount threshold, without proving clinical effectiveness.
Impact
Highest effect
Coenzyme Q-10 · 400 mg
Coenzyme Q-10 supports antioxidant and mitochondrial processes. Its anti-inflammatory findings come from a small trial of daily ubiquinone in statin-treated people with coronary artery disease, with changes in one marker but not others. The 400 mg serving exceeds the 300 mg daily study amount; more does not establish greater benefit.
How this product is rated for Inflammation
Ingredient fit86
Coenzyme Q-10 provide the relevant ingredient findings. Amounts and the wider formula determine the degree of alignment.
Goal fit
The relevant ingredient is the main focus, although it is also associated with other goals.
Dose adequacy
The relevant amounts provide partial alignment with the saved reference amounts, with some below the studied exposure.
Pathways52
The main connection is through antioxidant and mitochondrial processes. Coverage is concentrated in antioxidant and mitochondrial processes, rather than spread broadly across the evaluated routes.
Depth
The strongest finding concerns antioxidant and mitochondrial processes.
Breadth
Coverage is concentrated in antioxidant and mitochondrial processes, rather than spread broadly across the evaluated routes.
Evidence93
Coenzyme Q-10 leads the evidence finding. The reviewed material is recognized in the saved findings.
Evidence strength
Coenzyme Q-10 provides the leading evidence finding; the supported outcomes and populations limit how broadly it applies.
Studied preparation
The preparations receiving this finding are treated as matching the reviewed material; this does not establish the same daily regimen.
Formulation logic100
The relevant ingredients have no unmet partner requirement or configured conflict. Their amount thresholds do not establish clinical benefit.
Partner coverage
The relevant ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The ingredients counted here clear the saved amount threshold; that threshold does not prove an effective dose for every user.
Impact
High effect
Coenzyme Q-10 · 400 mg
CoQ10 participates in mitochondrial electron transport, which helps cells handle energy. The supplied clinical information concerns metabolic-control markers rather than a demonstrated increase in whole-body energy expenditure. Its amount receives full recognition in the saved findings, but that does not establish a faster resting metabolism or greater benefit from larger servings.
How this product is rated for Metabolism Support
Ingredient fit93
CoQ10 is the credited ingredient and receives full amount recognition.
Goal fit
The credited ingredients give the formula a clear connection to the reviewed metabolic functions.
Dose adequacy
The recognized ingredient amounts receive full consideration; this does not establish extra benefit above studied exposures.
Pathways54
CoQ10 supplies the mitochondrial-energy finding.
Depth
CoQ10 supplies the mitochondrial-energy finding.
Breadth
One pathway reaches the coverage threshold, leaving the findings concentrated in a single area.
Evidence75
CoQ10 mechanisms and metabolic-control findings do not establish increased whole-body energy expenditure.
Evidence strength
CoQ10 mechanisms and metabolic-control findings do not establish increased whole-body energy expenditure.
Studied preparation
The saved findings recognize the evaluated preparation, within the ingredient-specific limits of the supplied human evidence.
Formulation logic100
The recognized ingredients have their required partners or work independently, and no matched formulation conflict appears.
Partner coverage
Recognized ingredients have any required partner or work independently; no additional combination benefit is established.
Conflicts
No matched formulation conflict appears in the supplied findings.
Effective doses
All included ingredients meet this amount threshold; it is not a proven minimum effective dose or evidence of extra metabolic benefit.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q10 (Ubiquinone) | 400 mg | |
Black Pepper ext. (Piperine) | 5 mg |
Coenzyme Q-10 (Ubiquinone) · 400 mg OverallScore81
A serving provides 400 mg of CoQ10 as ubiquinone. A black pepper extract enhancer is recorded, but its amount and effect on this product’s absorption are not established.
How this ingredient is rated
Active Ingredient Quality & Bioavailability64
Ubiquinone is the recorded CoQ10 form, which the body converts to ubiquinol. A black pepper extract enhancer is recorded; its amount and its effect on this product’s absorption are not established.
Molecular Form: Ubiquinol vs. Ubiquinone
Ubiquinone is the recorded CoQ10 form, which the body converts to ubiquinol.
Formulation & Absorption Enhancers
A black pepper extract enhancer is recorded; its amount and its effect on this product’s absorption are not established.
Dose, Safety & Label Transparency88
A serving provides 400 mg of CoQ10 as ubiquinone. The available facts also record a standard filler.
Clinical Dosage Alignment
A serving provides 400 mg of CoQ10 as ubiquinone.
Label Transparency & Fillers
The 400 mg CoQ10 amount is recorded, and the available facts indicate a standard filler.
Value100
A whole-product serving costs about $0.55, equivalent to about $0.14 per 100 mg of CoQ10.
Price Per Effective Serving
The whole-product price is about $0.55 per serving, or $0.14 per 100 mg of CoQ10.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.